|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:bfsLayer
|
5
|
|
gptkbp:bfsParent
|
gptkb:Searle_Pharmaceuticals
|
|
gptkbp:activities
|
gptkb:television_channel
|
|
gptkbp:approves
|
gptkb:1993
|
|
gptkbp:brand
|
gptkb:Neurontin
|
|
gptkbp:category
|
gptkb:C
|
|
gptkbp:class
|
gptkb:drug
|
|
gptkbp:contraindication
|
hypersensitivity
severe renal impairment
|
|
gptkbp:current_use
|
gptkb:restless_legs_syndrome
bipolar disorder
fibromyalgia
postherpetic neuralgia
migraine prevention
|
|
gptkbp:developed_by
|
gptkb:Parke-Davis
|
|
gptkbp:dosage_form
|
300 mg to 600 mg daily
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:form
|
gptkb:beer
gptkb:tablet
oral solution
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Gabapentin
|
|
gptkbp:ingredients
|
C9 H17 N1 O2
|
|
gptkbp:interacts_with
|
antacids
opioids
|
|
gptkbp:is_atype_of
|
N03 A X12
|
|
gptkbp:is_used_for
|
seizures
anxiety disorders
neuropathic pain
|
|
gptkbp:legal_issue
|
prescription only
|
|
gptkbp:lifespan
|
5 to 7 hours
|
|
gptkbp:manager
|
oral
|
|
gptkbp:metabolism
|
renal
|
|
gptkbp:products
|
gptkb:Pregabalin
gptkb:Vigabatrin
|
|
gptkbp:research
|
gptkb:psychologist
chronic pain
sleep disorders
ADHD
anxiety treatment
tinnitus
autism spectrum disorder
diabetic neuropathy
cancer pain
alcohol withdrawal
neuropathic itch
|
|
gptkbp:side_effect
|
dizziness
fatigue
nausea
swelling
drowsiness
|